Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• Unique Fabricating, Inc. (NYSE:UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.
• Reata Pharmaceuticals, Inc. (NASDAQ:RETA) gained 53.3% to $166.41 after Biogen agreed to acquire the company.
• Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares gained 48.5% to $7.95.
• AEye, Inc. (NASDAQ:LIDR) shares climbed 48.5% to $0.3300 after falling around 4% on Thursday.
• View, Inc. (NASDAQ:VIEW) gained 40.4% to $15.45.
• Infobird Co., Ltd (NASDAQ:IFBD) gained 40% to $1.17.
• Business First Bancshares, Inc. (NASDAQ:BFST) rose 28% to $21.77 following upbeat quarterly results.
• Gracell Biotechnologies Inc. (NASDAQ:GRCL) climbed 24.3% to $3.9898.
• INVO Bioscience, Inc. (NASDAQ:INVO) gained 23% to $4.6189. INVO BioScience recently announced 1-for-20 reverse stock split.
• Mersana Therapeutics, Inc. (NASDAQ:MRSN) gained 22% to $1.3115. Mersana Therapeutics said that the UPLIFT clinical trial of upifitamab rilsodotin did not meet its primary endpoint.
• Roku, Inc. (NASDAQ:ROKU) jumped 20.8% to $82.43 after the company reported better-than-expected second-quarter results and issued strong third-quarter guidance.
• Larimar Therapeutics, Inc. (NASDAQ:LRMR) rose 20.5% to $3.75.
• Homology Medicines, Inc. (NASDAQ:FIXX) shares climbed 19.7% to $1.1250. Homology Medicines announced initial data from the first dose cohort in the pheEDIT Phase 1 dose-escalation trial evaluating gene editing candidate HMI-103 in adults with classical phenylketonuria (PKU). Homology will not be further developing its programs and will be instituting a related reduction in force while it explores options for the company and its assets, including HMI-103. The company is reducing its workforce by 87% and stopping further program development efforts outside of required actions, including continued collection of data from and monitoring of participants in its clinical trials.
• Huron Consulting Group Inc. (NASDAQ:HURN) gained 18.5% to $94.00 following upbeat quarterly results.
• TAL Education Group (NYSE:TAL) climbed 18.1% to $7.57. TAL Education released quarterly results yesterday.
• The Boston Beer Company, Inc. (NYSE:SAM) jumped 18.1% to $370.40 after the company yesterday reported better-than-expected quarterly results.
• Costamare Inc. (NYSE:CMRE) rose 17.1% to $11.12 following strong quarterly sales.
• Coursera, Inc. (NYSE:COUR) shares gained 16.3% to $15.13 following better-than-expected second-quarter sales results. Cantor Fitzgerald upgraded Coursera from Neutral to Overweight and raised the price target from $13 to $17.
• Beazer Homes USA, Inc. (NYSE:BZH) jumped 16.2% to $32.28 following better-than-expected quarterly results.
• Bilibili Inc. (NASDAQ:BILI) gained 15.4% to $18.70.
• Inpixon (NASDAQ:INPX) shares rose 15.1% to $0.2325 after falling around 20% on Thursday. Inpixon recently agreed to merge with XTI Aircraft Company.
• Celestica Inc. (NYSE:CLS) rose 14.8% to $20.69 after RBC Capital upgraded the stock from Sector Perform to Outperform and raised its price target from $14 to $22. TD Cowen also upgraded the stock from Hold to Buy and raised the price target from $14.5 to $23.
• SIGA Technologies, Inc. (NASDAQ:SIGA) gained 14.7% to $5.84 after the company announced a $138 million U.S. government contract for oral and IV TPOXX treatment.
• Silicon Motion Technology Corporation (NASDAQ:SIMO) rose 14.5% to $60.10 following strong quarterly sales.
• SkyWest, Inc. (NASDAQ:SKYW) surged 13.4% to $44.96 following second-quarter results.
• GDS Holdings Limited (NASDAQ:GDS) gained 13.4% to $13.59. Shares of Chinese stocks traded higher amid hopes of policy support and further stimulus measures.
• Cardlytics, Inc. (NASDAQ:CDLX) rose 12.3% to $10.81.
• T. Rowe Price Group, Inc. (NASDAQ:TROW) gained 10.5% to $129.47 after the company reported better-than-expected second-quarter financial results.
• Meritage Homes Corporation (NYSE:MTH) gained 8.4% to $149.99 following quarterly results.
• Skechers U.S.A., Inc. (NYSE:SKX) climbed 7.9% to $55.16 after the company reported better-than-expected second-quarter results.
• Intel Corporation (NASDAQ:INTC) shares rose 5.3% to $36.40 after the company reported better-than-expected second-quarter results and issued strong guidance.

Losers

• Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares declined 39% to $1.0850. Tonix Pharmaceuticals priced public offering of 7 million common shares at $1 per share.
• Sleep Number Corporation (NASDAQ:SNBR) fell 29.5% to $27.12 after the company reported mixed second-quarter results.
• Femasys Inc. (NASDAQ:FEMY) shares fell 22.5% to $0.6510. Femasys shares jumped over 130% on Thursday after the company announced that the United States Patent and Trademark Office issued a Notice of Allowance for FemBloc for permanent birth control.
• Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 20.8% to $2.0950. Eos Energy Enterprises said it expects second-quarter revenue of $0.2 million.
• Carmell Therapeutics Corporation (NASDAQ:CTCX) dropped 19.6% to $3.52. Carmell Therapeutics recently announced a merger with Axoloti Biologix.
• Fresh Vine Wine, Inc. (NYSE:VINE) shares fell 19.1% to $0.51. Fresh Vine Wine said on July 14, Roger Cockroft's employment with and service as CEO of the company ended and Hitesh Dheri's employment with and service as CFO ended.
• G Medical Innovations Holdings Ltd (NASDAQ:GMVD) declined 16% to $0.2899.
• GSI Technology, Inc. (NASDAQ:GSIT) fell 15.1% to $4.21 after posting a first-quarter loss.
• Gogo Inc. (NASDAQ:GOGO) fell 14.8% to $14.81.
• Genelux Corporation (NASDAQ:GNLX) declined 14.8% to $19.90.
• Mallinckrodt plc (NYSE:MNK) fell 13% to $1.41 after jumping over 28% on Thursday.
• Sweetgreen, Inc. (NYSE:SG) fell 12.2% to $13.56 after the company reported worse-than-expected second-quarter results.
• Enphase Energy, Inc. (NASDAQ:ENPH) shares fell 10.1% to $149.95 after the company posted downbeat second-quarter sales and issued weak sales guidance.
• Avantor, Inc. (NYSE:AVTR) fell 9.9% to $20.57 after the company reported worse-than-expected second-quarter financial results.
• MarineMax, Inc. (NYSE:HZO) declined 8.2% to $37.36. B. Riley downgraded MarineMax from Buy to Neutral and lowered the price target from $48 to $43.
• PennyMac Mortgage Investment Trust (NYSE:PMT) fell 7.7% to $13.09 following weak quarterly results.
• SolarEdge Technologies, Inc. (NASDAQ:SEDG) shares declined 5.4% to $228.77. Infineon and SolarEdge inked a multi-year capacity reservation supplier agreement to foster green energy solutions.
• Ford Motor Company (NYSE:F) shares slipped 3.9% to $13.19. Ford reported upbeat earnings for its second quarter and raised its FY23 adjusted EBIT guidance.

Now Read This: Bitcoin Falls; Synthetix, Pepe Among Top Losers